GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Corline Biomedical AB (OSTO:CLBIO) » Definitions » Total Equity

Corline Biomedical AB (OSTO:CLBIO) Total Equity : kr91.65 Mil (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Corline Biomedical AB Total Equity?

Corline Biomedical AB's total equity for the quarter that ended in Mar. 2024 was kr91.65 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Corline Biomedical AB Total Equity Historical Data

The historical data trend for Corline Biomedical AB's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corline Biomedical AB Total Equity Chart

Corline Biomedical AB Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 54.96 59.32 52.22 92.23 94.59

Corline Biomedical AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 94.59 95.61 93.74 93.92 91.65

Corline Biomedical AB Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Corline Biomedical AB's Total Equity for the fiscal year that ended in Dec. 2022 is calculated as

Total Equity=Total Assets(Q: Dec. 2022 )-Total Liabilities(Q: Dec. 2022 )
=101.783-7.194
=94.59

Corline Biomedical AB's Total Equity for the quarter that ended in Mar. 2024 is calculated as

Total Equity=Total Assets(Q: Mar. 2024 )-Total Liabilities(Q: Mar. 2024 )
=101.189-9.541
=91.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Corline Biomedical AB Total Equity Related Terms

Thank you for viewing the detailed overview of Corline Biomedical AB's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Corline Biomedical AB (OSTO:CLBIO) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Corline Biomedical AB (OSTO:CLBIO) » Definitions » Total Equity
Comparable Companies
OSTO:KAN OSTO:ACOU OSTO:MAGLE OSTO:GUARD OSTO:SANION OSTO:IMMU OSTO:ATORX OSTO:BIOWKS OSTO:IRLAB A OSTO:ABLI OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
Lefflersgatan 5, Uppsala, SWE, 754 50
Website
http://www.corline.com
Corline Biomedical AB is involved in developing, manufacturing and marketing heparin-based solutions to improve kidney transplantation, cell therapies, and applications in the field of regenerative medicine.

Corline Biomedical AB (OSTO:CLBIO) Headlines

No Headlines